Announcements

** HIV, AIDS, and Chinese Medicine Conference:
San Francisco State University, June 18-20

"HIV, AIDS, and Chinese Medicine: A first international
conference to explore the role of traditional Chinese medicine
(TCM) in the treatment of HIV and AIDS" will be held from Friday
evening, June 20, through that Sunday afternoon. It is sponsored
by the Institute of Holistic Healing Studies at San Francisco
State University, and the Chinese Medical Sciences Research
Institute, San Francisco. There are 14 co- sponsors; those most
likely to be familiar to our readers are Project Inform, Quan Yin
Healing Arts Center, and the Immune Enhancement Program, all
located in San Francisco, and the Institute for Traditional
Medicine, in Portland, Oregon.

The conference fee is $145; dormitory rooms and meals are
available for as little as $75 for the two days (shared room in a
residence hall). For a copy of the program, which includes a
list of presenters, call 415/453-2130.

** Leading Scientists to Address Town Forum, Washington,
D. C., June 2, 4:00-6:30 p. m.

Five leading AIDS experts, Anthony S. Fauci, M. D., Robert
C. Gallo, M. D., Enrico Garaci, M. D., Michael S. Gottleib, M.
D., and Robert R. Redfield, M. D., are scheduled to speak at "A
Town Forum on AIDS," on Wednesday, June 2, from 4:00 to 6:30 p.m.
at George Washington University's Lisner Auditorium, 730 21st St.
NW, in Washington, D. C. The meeting is convened by Allan L.
Goldstein, Ph.D., Professor and Chair of the Department of
Biochemistry and Molecular Biology of George Washington
University, and scientific director of the Institute for Advanced
Studies in Immunology and Aging; it will be moderated by Carole
Simpson of ABC News. For more information, call Alixe McNeill at
202/333-8845.

** Correction: DaunoXome Trial Sites Include Boston

A clinical trial of liposomal daunorubicin (brand name
DaunoXome) for treating Kaposi's sarcoma (KS) is being conducted
at ten cities across the U. S. AIDS TREATMENT NEWS #174 (May 7,
1993) listed those cities, but erroneously omitted Boston. The
correct list is: Boston, Chicago, Houston, Los Angeles, New
York, Palm Springs, Portland, San Francisco, Tucson, and
Washington.

In addition, there is a compassionate-use protocol of
DaunoXome for certain patients with advanced KS who do not
qualify for the trial. It is available in Boston, Los Angeles,
New York, and San Francisco. This list was correct in issue
#174.

For more information about either the trial or the
compassionate-use protocol, see the contact persons and phone
numbers in issue #174.